About KADASON
KADASON Medicated Shampoo is a US OTC drug for the symptoms of seborrheic dermatitis — flaking, scaling, and itching. It is formulated with salicylic acid 1.80%, a keratolytic that loosens scalp buildup, and is marketed under the FDA OTC Monograph (M032) with a Drug Facts label and NDC. Developed in Japan and marketed and distributed in the US by Ys Pharma Inc., New York.
Why your audience will care
Seborrheic dermatitis affects an estimated 5–6% of adults in the US. Most sufferers cycle through several shampoos before finding one that keeps symptoms under control. KADASON is built for that audience: a single, consistent daily-use product rather than a general dandruff shampoo. Direct site price is $34.99 (8 fl oz / 237 mL), with subscription pricing available.
Program terms
- Competitive commission on the customer's first order (net of tax and shipping) — see the Commissions tab for current rates
- 30-day last-click cookie
- Monthly payments through Awin
- Custom rates for content publishers with relevant scalp-health or dermatology audiences — get in touch
What we provide
- Product images, Drug Facts, and ingredient information
- Clinical references for medical review (OTC monograph documentation, peer-reviewed literature)
- Samples for testing and editorial review on request
- Responsive support from our team in English
Who we are looking for
Health and beauty content sites, skincare and scalp-care creators, and dermatology-focused publishers. We especially welcome partners who write for people managing seborrheic dermatitis.
Please note
No bidding on KADASON brand terms in paid search. Coupon codes may only be published if issued through this program. Please describe the product using the symptom language above; KADASON relieves symptoms and does not cure or treat the underlying condition.
